Markus Hosang

Dr. Markus Hosang has a strong pharmaceutical and VC background and joined BioMedPartners in 2004. He was Venture Partner at MPM Capital, where he was co-responsible for their European deal flow, managed the European office in Munich, and served on the board of several portfolio companies.

Prior to joining MPM in 2002, he was at Roche, where he served for nearly 20 years in several senior management positions in the Pharma R&D organization, including VP and Director of the International Pharma Research Strategy Unit and Chief of Staff to the President of Roche Global R&D. He organized and served on the Global Board of R&D Directors and the Pharma Portfolio Board. Most recently he was VP and CSO of Genetics and Integrated Medicine and a member of the Roche Genetics Executive Committee.

Dr. Hosang received his M.S. and Ph.D. degrees in Biochemistry from the ETH in Zurich, and pursued his postgraduate training at Stanford University Medical School and at the University of Washington in Seattle. He served as a member of the Board and as the Treasurer of the Swiss Foundation for Stipends in Biology and Medicine for many years.